Tag: clinical trial phases

Risk Management Plans (RMPs) and REMS Requirements in Phase 4 Clinical Trials Understanding RMPs and REMS: How Phase 4 Trials Ensure Drug Safety Post-Approval What Are RMPs and REMS in the Context of Phase 4 Trials? Risk Management Plans (RMPs) and Risk Evaluation and Mitigation Strategies (REMS) are structured plans developed to ensure that the…

Read More “Risk Management Plans (RMPs) and REMS Requirements in Phase 4 Clinical Trials” »

Pharmacovigilance and Safety Signal Detection in Phase 4 Clinical Trials How Pharmacovigilance and Signal Detection Work in Post-Marketing Surveillance What Is Pharmacovigilance in the Context of Phase 4? Pharmacovigilance (PV) refers to the science and activities involved in detecting, assessing, understanding, and preventing adverse effects or any other drug-related problems. In Phase 4—or post-marketing surveillance—pharmacovigilance…

Read More “Pharmacovigilance and Safety Signal Detection in Phase 4 Clinical Trials” »

Regulatory Expectations for Phase 4 Studies Globally: FDA, EMA, CDSCO, PMDA & More Global Regulatory Requirements for Phase 4 Clinical Trials: A Country-by-Country Guide Why Regulatory Oversight in Phase 4 Is Critical Once a product receives regulatory approval and enters the market, its journey doesn’t end—rather, it transitions into a new phase: post-marketing surveillance, or…

Read More “Regulatory Expectations for Phase 4 Studies Globally: FDA, EMA, CDSCO, PMDA & More” »

Differences Between Phase 3 and Phase 4 Trials: From Controlled Research to Real-World Practice Phase 3 vs Phase 4 Trials: Key Differences Every Researcher Should Know Why Understanding the Differences Matters Clinical trials progress through a structured series of phases, with Phase 3 and Phase 4 being the final and most public-facing stages. While both…

Read More “Differences Between Phase 3 and Phase 4 Trials: From Controlled Research to Real-World Practice” »

What are Phase 4 (Post-Marketing) Clinical Trials? A Complete Overview for Clinical Researchers Understanding Phase 4 Clinical Trials: What Happens After Drug Approval What Are Phase 4 Trials and Why Are They Conducted? Phase 4 clinical trials, often referred to as post-marketing studies, are conducted after a drug or therapy has received regulatory approval and…

Read More “What are Phase 4 (Post-Marketing) Clinical Trials? A Complete Overview for Clinical Researchers” »